The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the …
P Lancellotti, PA Pellikka, W Budts… - European Heart …, 2016 - academic.oup.com
A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …
Management of asymptomatic severe aortic stenosis: evolving concepts in timing of valve replacement
New insights into the pathophysiology and natural history of patients with aortic stenosis,
coupled with advances in diagnostic imaging and the dramatic evolution of transcatheter …
coupled with advances in diagnostic imaging and the dramatic evolution of transcatheter …
2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations
In the past several decades, cardiopulmonary exercise testing (CPX) has seen an
exponential increase in its evidence base. The growing volume of evidence in support of …
exponential increase in its evidence base. The growing volume of evidence in support of …
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized …
J Bermejo, R Yotti, R García-Orta… - European Heart …, 2018 - academic.oup.com
Aims We aimed to determine whether treatment with sildenafil improves outcomes of
patients with persistent pulmonary hypertension (PH) after correction of valvular heart …
patients with persistent pulmonary hypertension (PH) after correction of valvular heart …
Nrf2 in health and disease: current and future clinical implications
O Al-Sawaf, T Clarner, A Fragoulis, YW Kan… - Clinical …, 2015 - portlandpress.com
The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is a major regulator
of oxidative stress defence in the human body. As Nrf2 regulates the expression of a large …
of oxidative stress defence in the human body. As Nrf2 regulates the expression of a large …
Pulmonary hypertension in aortic and mitral valve disease
MT Maeder, L Weber, M Buser, M Gerhard… - Frontiers in …, 2018 - frontiersin.org
In patients with aortic and/or mitral valve disease the presence of pulmonary hypertension
(PH) indicates a decompensated state of the disease with left ventricular and left atrial …
(PH) indicates a decompensated state of the disease with left ventricular and left atrial …
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European …
O Chioncel, M Adamo, M Nikolaou… - European Journal of …, 2023 - Wiley Online Library
Acute heart failure (AHF) represents a broad spectrum of disease states, resulting from the
interaction between an acute precipitant and a patient's underlying cardiac substrate and …
interaction between an acute precipitant and a patient's underlying cardiac substrate and …
Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction
JA Lindenfeld, MR Costanzo, MR Zile… - Journal of the American …, 2024 - jacc.org
Background Trials evaluating implantable hemodynamic monitors to manage patients with
heart failure (HF) have shown reductions in HF hospitalizations but not mortality. Prior meta …
heart failure (HF) have shown reductions in HF hospitalizations but not mortality. Prior meta …
Impact of periprocedural pulmonary hypertension on outcomes after transcatheter aortic valve replacement
J Miyamoto, Y Ohno, N Kamioka, Y Ikari… - Journal of the American …, 2022 - jacc.org
Background There are limited data on the prognostic impact of periprocedural pulmonary
hypertension (PH) after transcatheter aortic valve replacement (TAVR). Objectives The aim …
hypertension (PH) after transcatheter aortic valve replacement (TAVR). Objectives The aim …
Exercise-induced signaling pathways to counteracting cardiac apoptotic processes
HA Pahlavani - Frontiers in Cell and Developmental Biology, 2022 - frontiersin.org
Cardiovascular diseases are the most common cause of death in the world. One of the major
causes of cardiac death is excessive apoptosis. However, multiple pathways through …
causes of cardiac death is excessive apoptosis. However, multiple pathways through …